Search papers, labs, and topics across Lattice.
1
0
0
11
The clinical relevance of HRD and MSI as therapeutic targets and predictive biomarkers across various tumor types are discussed, and the evolving landscape of resistance to PARP inhibitors and ICIs, and the emergence of novel targets within the DNA damage response (DDR) pathway are detailed.